Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032

Overview

The Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market is expected to reach a 24.32 USD Billion by 2032 and is projected to grow at a CAGR of 10.37% from 2025 to 2032.

Revenue, 2024 (USD Billion)

14.52

Forecast, 2032 (USD Billion)

24.32

CAGR, 2024 - 2032

10.37%

Report Coverage

Global

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market 2018-2032 USD Billion

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 14.52 USD Billion
Projected Market Size (2032): 24.32 USD Billion
CAGR (2025-2032): 10.37%

Key Findings of Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market

The Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market was valued at 14.52 USD Billion in 2024.
The Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market is likely to grow at a CAGR of 10.37% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Wet AMD in Type Segment accounted for the largest share of the market with a revenue of 13.20 USD Billion
The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 11.95% during the forecast period from 2024 to 2032.

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market Scope

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market Segmentation & Scope

Distribution Channel

Direct Tender
Retail Sales

End User

Others
Home Healthcare
Ambulatory Surgical Centers
Specialty Clinics
Hospitals

Type

Dry AMD
Wet AMD

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market Data Coverage Insights

Study Period	2024-2032
Base Year	2020
Unit	Revenue in USD Billion
Market Value in 2024	14.52 USD Billion
Market Value in 2032	24.32 USD Billion
CAGR (2025-2032)	10.37%
Historic Data	2016-2023
Market Segments Covered	Distribution Channel,End User,Type

Regional Insights:

Leading Market (2024-2032): Global, leading in terms of revenue 14.52 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 5,740.20 USD Million in 2024.

Segments and Scope

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032, By Distribution Channel
- Retail Sales is the largest segment in Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032 with a revenue of 9.02 USD Billion in the year 2024.
- Retail Sales is the Fastest growing segment in Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032 with a Growth rate of 10.92 % in forecast period 2025-2032.
Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032, By End User
- Hospitals is the largest segment in Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032 with a revenue of 6.68 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032 with a Growth rate of 11.95 % in forecast period 2025-2032.
Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032, By Type
- Wet AMD is the largest segment in Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032 with a revenue of 13.20 USD Billion in the year 2024.
- Wet AMD is the Fastest growing segment in Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market to 2032 with a Growth rate of 10.43 % in forecast period 2025-2032.

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market Company Share Analysis

Company Name
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
Genentech, Inc.
IVERIC bio, Inc.

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market Geographical Sales Distribution, 2018-2032 USD Billion

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market Company Profiling

Industry Related Reports

Global Scleroderma Treatment Market

Global Cold Sore Treatment Market

Global Drug-Device Combination Market

Global Down Syndrome Market

Global Small Molecule Sterile Injectable Drugs Market

Global Lymphangioleiomyomatosis (LAM) Market

Global Medicinal Chemistry for Drug Discovery Market

Global Laxative Market

Global Dandruff Treatment Market

Global Dengue Treatment Market

Frequently Asked Questions

What are the primary segments covered in the Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market?

The Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market is segmented based on Segmentation Distribution Channel,End User,Type.

What is the current market size of the Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market?

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market was valued at USD 14.52(Revenue in USD Billion) in 2020.

What is the expected growth rate of the Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market?

Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market is projected to grow at a CAGR of 10.37% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market?

The Wet AMD segment is expected to dominate the Global Age-Related Macular Degeneration (AMD) Disease - ANTI VGEF Market, holding a largest market share of 13.20 USD Billion in 2024

Coming Soon....